glp-1 drugs news today like Ozempic linked to slower cancer spread, study finds GLP-1 drugs like Ozempic deliver

Improvements in neuropathy severity scores and sensory nerve conduction were observed, and follow-up at three months indicated sustained reductions in nerve CSA and enhanced clinical outcomes

doi: 10.1503/cmaj.101281 Summary Keywords sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, type 2 diabetes, metformin, meta-analysis Citation Deng R, Mei K, Song T, Huang J, Wu Y, Yu P, Yan Z and Liu X (2024) First-line treatment with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in type 2 diabetic population at low risk of cardiovascular disease: a meta-analysis

Retrieved from do Nascimento TS, Pereira RO, Maia E, Ohnuma T, da Costa, MG, Slawka E, Galhardo Jr C, Krishnamoorthy V

Nausea, vomiting, diarrhea, and constipation are among the most common, especially when starting treatment or increasing doses

[DOI] [PubMed] [Google Scholar] 44.Hay DL, Pioszak AA

Indiana University-Purdue University Indianapolis